Showing results (1251-1260 of 1,373) with videos related to

Sort By:
Pageof 138
Blood|September 24, 2025
Prognostic value of premaintenance FDG PET/CT response in patients with newly diagnosed myeloma from the CASSIOPEIA trialFrançoise Kraeber-Bodéré, Bastien Jamet, Sonja Zweegman, et al.
Blood|July 29, 2006
Maintenance therapy with thalidomide improves survival in patients with multiple myelomaMichel Attal, Jean-Luc Harousseau, Serge Leyvraz, et al.
European Journal of Haematology|October 26, 2011
Low-dose vs. high-dose thalidomide for advanced multiple myeloma: a prospective trial from the Intergroupe Francophone du MyélomeIbrahim Yakoub-Agha, Jean-Yves Mary, Cyrille Hulin, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|December 20, 2019
Validation of an automated ASPECTS method on non-contrast computed tomography scans of acute ischemic stroke patientsHulin Kuang, Wu Qiu, Mohamed Najm, et al.
Frontiers in Oncology|November 29, 2023
Integrated analysis of randomized controlled trials evaluating bortezomib + lenalidomide + dexamethasone or bortezomib + thalidomide + dexamethasone induction in transplant-eligible newly diagnosed multiple myelomaLaura Rosiñol, Benjamin Hebraud, Albert Oriol, et al.
Haematologica|August 28, 2025
Assessing the benefit of incorporating an anti-CD38 monoclonal antibody into second- or third-line systemic treatment for patients with relapsed/refractory multiple myeloma: results from the French real-world EMMY studyThomas Chalopin, Cyrille Hulin, Bruno Royer, et al.
Molecular Therapy. Methods & Clinical Development|August 29, 2024
A pseudotyped adenovirus serotype 5 vector with serotype 49 fiber knob is an effective vector for vaccine and gene therapy applicationsCarly M Bliss, Sarah L Hulin-Curtis, Marta Williams, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 2, 2012
Long-term analysis of the IFM 99 trials for myeloma: cytogenetic abnormalities [t(4;14), del(17p), 1q gains] play a major role in defining long-term survivalHervé Avet-Loiseau, Michel Attal, Loic Campion, et al.
Journal of Medical Economics|February 17, 2026
Indirect treatment comparison of DVRd plus DR maintenance (PERSEUS study) versus DVTd or VTd with or without lenalidomide maintenance in transplant-eligible patients with previously untreated multiple myelomaMeletios A Dimopoulos, Mario Boccadoro, Hermann Einsele, et al.
Clinical Hematology International|July 25, 2024
The EMMY longitudinal, cohort study: real-world data to describe multiple myeloma management and outcomes as more therapeutic options emergeOlivier Decaux, Ronan Garlantézec, Karim Belhadj-Merzoug, et al.
Pageof 138